A chronic, painless lip swelling proved diagnostically challenging until histology showed epithelioid granulomas and excluded infection and sarcoidosis.
Internal documents show contractor readiness concerns, decision delays, and high non-affirmation rates, while providers ...
Asthma flare-ups spike in the weeks after school starts, when viral exposure, allergens, and missed maintenance treatment can ...
Survivors of bacterial meningitis have modestly higher mortality than their peers over nearly six decades, and their siblings ...
Cancer diagnoses among people exposed to the World Trade Center disaster continue to be reported 25 years after 9/11, ...
JAK inhibitors are linked to reduced disease activity and improved patient-reported outcomes in patients with rheumatoid arthritis, regardless of diabetes, cardiometabolic burden, or age.
A new survey examines young adults’ use of primary care, Nebraska receives funding for rural training, and Trinity Health expands services in West Michigan.
Abemaciclib and ribociclib now show adjuvant survival benefit; palbociclib didn't. Laura Spring, MD, on picking the right agent per patient.
Apitegromab is the first SMA therapy to directly target muscle loss and is approved as add-on treatment for patients aged 2 years and older receiving an SMN2-targeted therapy.
Amid the backlash against paternalism and efforts to rebuild trust, an important ethical principle got caught in the fallout: ...
The modified Medical Research Council questionnaire (mMRC) and COPD Assessment Test (CAT) are objective measures of symptoms in patients with COPD, said lead author Andrew J. Gangemi, MD, associate ...
The agency expresses concern that a rise in use of postexposure prophylaxis could indicate a lack of understanding of when to administer the therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results